FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
Log in

BAX

Baxter InternationalNYSE · Health Care Equipment · Health Care
Previous close
23.53
Change
−0.18 / −0.76%
FinDog View
Neutral
52-Week Range
15.73 – 30.00
P/E (TTM)
—
Forward P/E
13.6
Based on consensus earnings for the next 12 months
Market Cap
$12.2B
1M
−9.19%
S&P 500 −2.41% over same period
Volume / Avg Volume
9.4M / 5.6M
1.69× average

Price History

Closing price · USD1M6M1Y5Y
15202530FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 Earnings2025-092025-122026-032026-062026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-30$3.0B0.56 / 0.37−2.21%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-04-30$2.7B0.36 / 0.31−2.10%Read analysis →
FY2025 Q4
Quarter ended 2025-12
2026-02-12—— / —+5.77%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-30—— / —−3.60%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-31—— / —+0.92%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-01—— / —+0.13%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
A 5-year P/E range needs a longer earnings record; not yet comparable
Last 4 quarters: $0 in buybacks + $184M in dividends, 1.51% of market cap combined
P/E (TTM)
—
P/B
2.0
P/S
1.1
Dividend Yield
3.22%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.5% on average on the first trading day after, rising 3 times
Most recent −2.21%
Volatility & Correlation
1-year beta 1.17 · Correlation with S&P 500 0.35Tracks the market
Annualized volatility 43% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q22.96+5.3%34.9%0.220.130.290.24
FY2026 Q12.70+2.9%33.0%0.07-0.020.21-0.03
FY2025 Q42.97+8.0%19.4%-0.73-1.130.58-2.21
FY2025 Q32.84+5.0%33.5%0.17-0.050.24-0.09
FY2025 Q22.81+4.3%35.3%0.190.090.220.18
FY2025 Q12.63+5.4%32.8%0.060.13-0.190.25
FY2024 Q42.75+0.9%——-0.510.49-1.00
FY2024 Q32.70+3.8%38.3%0.160.140.250.27
FY2024 Q22.69+4.0%38.3%0.18-0.310.12-0.61
FY2024 Q12.49+2.0%38.6%0.120.040.160.07
FY2023 Q42.73−27.1%——0.250.530.48
FY2023 Q32.60−28.0%40.6%0.182.510.374.93

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
BAXBaxter International$12.2B—+5.3%34.9%−9.19%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare